Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
Canellos, G.P.
Leukemia 10(Suppl 2): S68
1996
ISSN/ISBN: 0887-6924 PMID: 8649055 Document Number: 455392
Document emailed within 1 workday
Related Documents
Brusamolino, E.; Lazzarino, M.; Morra, E.; Inverardi, D.; Merante, S.; Castelli, G.; Canevari, A.; Dornini, G.; Bernasconi, C. 1989: Combination chemotherapy with alternating MOPP-ABVD in advanced Hodgkin's disease Haematologica 74(2): 173-179Bonadonna, G.; Santoro, A.; Bonfante, V.; Valagussa, P. 1982: Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results Cancer Treatment Reports 66(4): 881-887
Molnár, Z.; Schneider, T.; Várady, E.; Fleischmann, T. 1997: ABVD chemotherapy of Hodgkin's disease Neoplasma 44(4): 263-265
Villani, F.; Dell'Oca, I.; De Maria, P.; Viola, G.; Di Russo, A.; Viviani, S.; Bonfante, V. 1999: Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's disease Anticancer Research 19(5c): 4475-4479
Vassilakopoulos, T.P.; Nadali, G.; Angelopoulou, M.K.; Dimopoulou, M.N.; Siakantaris, M.P.; Kontopidou, F.N.; Karkantaris, C.; Kokoris, S.I.; Dimitriadou, E.M.; Calpadaki, C.; Sarantopoulos, A.; Galani, Z.; Sachanas, S.; Kyrtsonis, M.C.; Tsaftaridis, P.; Variamis, E.; Panayotidis, P.; Pizzolo, G.; Sarris, A.H.; Pangalis, G.A. 2005: Beta(2)-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens Journal of BUON: Official Journal of the Balkan Union of Oncology 10(1): 59-69
Bonadonna, G.; Valagussa, P.; Santoro, A. 1986: Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results Annals of Internal Medicine 104(6): 739-746
Kozai, Y.; Ohyama, T.; Kodo, H.; Tomori, G. 1992: Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(14): 2407-2409
Lauria, F.; Baccarani, M.; Barbieri, E.; Fiacchini, M.; Gobbi, M.; Tura, S.; Baccarani, M. 1975: Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) Haematologica 60(1): 73-84
Armata, J. 1977: Chemotherapy program for treatment of Hodgkin's disease refractory to MOPP or MVPP Polski Tygodnik Lekarski 32(37): 1441-1443
Santoro, A.; Viviani, S.; Villarreal, C.J.; Bonfante, V.; Delfino, A.; Valagussa, P.; Bonadonna, G. 1986: Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP Cancer Treatment Reports 70(3): 343-348
Diehl, L.F.; Perry, D.J.; Terebelo, H.; Baldwin, P.E.; Hurwitz, M.; Kimball, D.B.; Dorn, R.V. 1983: Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy Cancer Treatment Reports 67(9): 827-829
Fazio, M.; Airoldi, M.; Bellardo, A.; Cavallero, P.; Mastromatteo, V.; Minnella, R.; Pecchio, F. 1981: Evaluation of serum BuChe activity during polychemotherapy based on COP and C-MOPP protocols Bollettino della Societa Italiana di Biologia Sperimentale 57(24): 2512-2518
Andrieu, J.M.; Ochoa-Molina, M.E. 1982: Pregnancies and offspring after MOPP therapy La Nouvelle Presse Medicale 11(49): 3623-3625
Komarnicki, M.; Balcerzak, A.; Górski, P.; Pawlak, L.; Hansz, J. 1994: Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine) Acta Haematologica Polonica 25(4): 363-368
Molina, J.M.; Chêuc, G.; Ferchal, F.; Journot, V.; Pellegrin, I.; Sombardier, M.N.; Rancinan, C.; Cotte, L.; Madelaine, I.; Debord, T.; Decazes, J.M. 1999: Results of the ALBi trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients Antiviral Therapy 4(Suppl 3): 71-74
Ho, P.C.; Kwan, M.S. 1993: A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception Human Reproduction 8(3): 389-392
L.P.ole, C.; Weijmer, M.; Van Ittersum, F.; Valentijn, R.; Ter Wee, P. 2002: Outcome of routine laboratory data after 30 weeks of treatment with a PD regimen low in glucose and GDPs or a standard PD regimen in newly CAPD patients Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 200A
Vlok, G.J.; van Vuren, J.P. 1987: Comparison of a standard ibuprofen treatment regimen with a new ibuprofen/paracetamol/codeine combination in chronic osteo-arthritis South African Medical Journal 1: 4-1, 6
Gao, W.; Cheng, H.; Hu, F.-l.; Lü, N.-h.; Xie, Y.; Sheng, J.-q.; Xu, J.-m.; Zhang, L.-x.; Zhang, L.; Chen, Y.; Zhang, Z.-y.; Zhang, G.-x.; Cui, M.-h.; Yang, G.-b.; Gao, H.-j.; Yang, L. 2012: Ilaprazole based bismuth-containing quadruple regimen for the first-line treatment of Helicobacter pylori infection: a multicenter, randomized, controlled clinical study Zhonghua Yi Xue Za Zhi 92(30): 2108-2112
Bennish, M.L.; Salam, M.A.; Khan, W.A.; Khan, A.M. 1992: Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial Annals of Internal Medicine 117(9): 727-734